These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 18381288)

  • 1. Alpha1 soluble guanylyl cyclase (sGC) splice forms as potential regulators of human sGC activity.
    Sharina IG; Jelen F; Bogatenkova EP; Thomas A; Martin E; Murad F
    J Biol Chem; 2008 May; 283(22):15104-13. PubMed ID: 18381288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative splicing impairs soluble guanylyl cyclase function in aortic aneurysm.
    Martin E; Golunski E; Laing ST; Estrera AL; Sharina IG
    Am J Physiol Heart Circ Physiol; 2014 Dec; 307(11):H1565-75. PubMed ID: 25239802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional role of the soluble guanylyl cyclase alpha(1) subunit in vascular smooth muscle relaxation.
    Nimmegeers S; Sips P; Buys E; Brouckaert P; Van de Voorde J
    Cardiovasc Res; 2007 Oct; 76(1):149-59. PubMed ID: 17610859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one inhibits neurite outgrowth and causes neurite retraction in PC12 cells independently of soluble guanylyl cyclase.
    Lee HG; Kim SY; Kim du S; Seo SR; Lee SI; Shin DM; De Smet P; Seo JT
    J Neurosci Res; 2009 Jan; 87(1):269-77. PubMed ID: 18711750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide receptor soluble guanylyl cyclase undergoes splicing regulation in differentiating human embryonic cells.
    Sharin VG; Mujoo K; Kots AY; Martin E; Murad F; Sharina IG
    Stem Cells Dev; 2011 Jul; 20(7):1287-93. PubMed ID: 20964618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the soluble guanylyl cyclase alpha1/alpha2 subunits in the relaxant effect of CO and CORM-2 in murine gastric fundus.
    De Backer O; Elinck E; Sips P; Buys E; Brouckaert P; Lefebvre RA
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Nov; 378(5):493-502. PubMed ID: 18563392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of soluble guanylate cyclase in NO-induced increases in aqueous humor outflow facility and in the trabecular meshwork.
    Ellis DZ; Dismuke WM; Chokshi BM
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1808-13. PubMed ID: 19074804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Notch activation augments nitric oxide/soluble guanylyl cyclase signaling in immortalized ovarian surface epithelial cells and ovarian cancer cells.
    El-Sehemy A; Chang AC; Azad AK; Gupta N; Xu Z; Steed H; Karsan A; Fu Y
    Cell Signal; 2013 Dec; 25(12):2780-7. PubMed ID: 24041655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrogen peroxide alters splicing of soluble guanylyl cyclase and selectively modulates expression of splicing regulators in human cancer cells.
    Cote GJ; Zhu W; Thomas A; Martin E; Murad F; Sharina IG
    PLoS One; 2012; 7(7):e41099. PubMed ID: 22911749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of soluble guanylate cyclase alpha(1) and alpha(2), and SK(Ca) channels in NANC relaxation of mouse distal colon.
    Dhaese I; Vanneste G; Sips P; Buys E; Brouckaert P; Lefebvre RA
    Eur J Pharmacol; 2008 Jul; 589(1-3):251-9. PubMed ID: 18572161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional properties of a naturally occurring isoform of soluble guanylyl cyclase.
    Russwurm M; Behrends S; Harteneck C; Koesling D
    Biochem J; 1998 Oct; 335 ( Pt 1)(Pt 1):125-30. PubMed ID: 9742221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology of the nitric oxide receptor, soluble guanylyl cyclase, in cerebellar cells.
    Bellamy TC; Garthwaite J
    Br J Pharmacol; 2002 May; 136(1):95-103. PubMed ID: 11976273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble guanylyl cyclase expression is reduced in LPS-induced lung injury.
    Glynos C; Kotanidou A; Orfanos SE; Zhou Z; Simoes DC; Magkou C; Roussos C; Papapetropoulos A
    Am J Physiol Regul Integr Comp Physiol; 2007 Apr; 292(4):R1448-55. PubMed ID: 17204594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of p53 and suppression of apoptosis by the soluble guanylyl cyclase/cGMP pathway in human ovarian cancer cells.
    Fraser M; Chan SL; Chan SS; Fiscus RR; Tsang BK
    Oncogene; 2006 Apr; 25(15):2203-12. PubMed ID: 16288207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the human alpha1 beta1 soluble guanylyl cyclase promoter: key role for NF-kappaB(p50) and CCAAT-binding factors in regulating expression of the nitric oxide receptor.
    Marro ML; Peiró C; Panayiotou CM; Baliga RS; Meurer S; Schmidt HH; Hobbs AJ
    J Biol Chem; 2008 Jul; 283(29):20027-36. PubMed ID: 18474600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of soluble guanylate cyclase by ODQ.
    Zhao Y; Brandish PE; Di Valentin M; Schelvis JP; Babcock GT; Marletta MA
    Biochemistry; 2000 Sep; 39(35):10848-54. PubMed ID: 10978171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA splicing in regulation of nitric oxide receptor soluble guanylyl cyclase.
    Sharina IG; Cote GJ; Martin E; Doursout MF; Murad F
    Nitric Oxide; 2011 Oct; 25(3):265-74. PubMed ID: 21867767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble guanylyl cyclase expression is reduced in allergic asthma.
    Papapetropoulos A; Simoes DC; Xanthou G; Roussos C; Gratziou C
    Am J Physiol Lung Cell Mol Physiol; 2006 Jan; 290(1):L179-84. PubMed ID: 16143586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3,-a] quinoxalin-1-one is a nonselective heme protein inhibitor of nitric oxide synthase and other cytochrome P-450 enzymes involved in nitric oxide donor bioactivation.
    Feelisch M; Kotsonis P; Siebe J; Clement B; Schmidt HH
    Mol Pharmacol; 1999 Aug; 56(2):243-53. PubMed ID: 10419542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interfacial residues promote an optimal alignment of the catalytic center in human soluble guanylate cyclase: heterodimerization is required but not sufficient for activity.
    Seeger F; Quintyn R; Tanimoto A; Williams GJ; Tainer JA; Wysocki VH; Garcin ED
    Biochemistry; 2014 Apr; 53(13):2153-65. PubMed ID: 24669844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.